Clearside Biomedical shareholders approve doubling authorized common stock to 400M shares

Clearside Biomedical, Inc.

Shareholders approved amendment to increase authorized common shares from 200M to 400M; 38.8M for, 10.3M against, 0.6M abstain.
All three director nominees (Lasezkay, Shaffer, Gibney) were elected with >25M votes for.
Advisory vote on executive compensation approved: 18.9M for, 3.4M against, 6.8M abstain.
Ratification of Ernst & Young as auditor for FY2025 approved: 48.5M for, 1.2M against.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Clearside Biomedical, Inc.: Increased authorized shares of common stock from 200,000,000 to 400,000,000 (effective 2025-05-30).

Change: charter amendment
Effective: 2025-05-30

Exact text from the filing

the Company’s stockholders approved an amendment to the Company’s Amended and Restated Certificate of Incorporation (the “ Amendment ”) to increase the authorized number of shares of common stock from 200,000,000 to 400,000,000

View on SEC.gov

42 governance changes filed in the last 30 days. Browse all governance changes →

Clearside Biomedical, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-25-079689

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.